Webinar WADD: Dual Disorders patients during COVID-19 pandemic time

 Webinar WADD: Dual Disorders patients during COVID-19 pandemic time

INTRODUCTION: We are living very complex and stressful times. The lives of many people around the world are affected by coronavirus pandemic. This situation impacts each person in a different way. Our concern is that the people struggling with Dual Disorders, Addiction and other Mental Disorders should not be overlooked.

The World Association on Dual Disorders (WADD) has decided to hold a webinar in this context, that will take the opportunity to get together partners from different parts of the World, discussing challenges and other perspectives regarding patients with dual disorders during COVID-19 Pandemic Time.

This Webinar perspective offered by the WADD is unique since there are forums for addictions and others for mental disorders, but we know that our patients suffer from dual disorders.

DATE & HOUR: 28th May 2020. 3 PM CEST (Continental European Summer Time), 2 PM BST (British Standard Time). 9 AM EST (Eastern Standard Time).

WEBINAR ORGANIZED BY: World Association on Dual Disorders (WADD).

AGENDA
3 PM CEST (Continental European Summer Time).

OPENING

3.00 pm WELCOME
Pedro Ruiz, President of WADD (USA).

3.02 pm YATAN BALHARA (INDIA) AND JOSE MARTINEZ-RAGA (SPAIN)
(introducing the speakers)

3.03 pm INTRODUCTION TO 1º WADD WEBINAR. FOCUS ON COVID-19 Nestor Szerman, Vice President of WADD (Spain) Icro Maremmani, Secretary of WADD (Italy).

3.10 pm DUAL DISORDERS PATIENTS DURING THE COVID-19 PANDEMIC. Caroline Salom (Australia).

3.15 pm DUAL DISORDER PATIENTS COVID-19. SPECIFIC DIFFICULTIES IN WOMEN. Gabrielle Fischer (Austria).

3.18 pm DUAL DISORDER, COVID-19 AND THE HOMELESS Christian Schutz (Canada).

3.21 pm DUAL DISORDERS PATIENT-COVID-19 AND INFECTIOUS DISEASES. Lisa Blecha (France).

DUAL DISORDERS AND COVID-19

3.24 pm DUAL DISORDER PATIENT-COVID-19. THE EFFECT OF THE COVID-19 EPIDEMIC ON SUICIDE RISK IN INDIVIDUALS WITH DUAL DISORDERS.
Leo Sher (USA).

3.27 pm DUAL DISORDERS PATIENT-COVID-19 AND SELF-MEDICATION. Miguel Casas (Spain).

3.30 pm DUAL DISORDER PATIENT-COVID-19 AND IMPULSIVITY (ADHD) José María Martinez-Raga (Spain).

3.33 pm DUAL DISORDERS PATIENT- COVID-19 AND DEPRESSION.
Marta Torrens (Spain).

3.36 pm DUAL DISORDERS PATIENT-COVID-19 AND CANNABIS.
Shaul Lev-Ran (Israel).

3.39 pm DUAL DISORDERS PATIENT-COVID-19. WHAT ABOUT TOBACCO? Nestor Szerman (Spain).

3.42 pm DUAL DISORDER PATIENT-COVID-19. OPIATE USE DISORDER PATIENTS.
Icro Maremanni (Italy).

3.45 pm DUAL DISORDERS PATIENT. COVID-19 AND ALCOHOL.
Carlos Roncero (Spain).

INTERNATIONAL PERSPECTIVES BY COUNTRIES

3.48 pm DUAL DISORDER PATIENT-COVID-19 IN MEXICO Rodrigo Marín (Mexico).

3.51 pm DUAL DISORDERS PATIENT-COVID-19 IN INDIA Yatan Balhara (India).

3.54 pm DUAL DISORDERS- COVID-19 IN SWITZERLAND
Lola Peris (Switzerland).

3.57 pm DUAL DISORDERS. COVID-19 IN PORTUGAL
Celia Franco (Portugal).

3.59 pm DUAL DISORDERS- COVID-19 IN FRANCE Amine Benyamina (France).

INTERNATIONAL PERSPECTIVES BY ORGANIZATIONS

4.02 pm DUAL DISORDERS AND COVID-19, THE PAN AMERICAN HEALTH ORGANIZATION (PAHO) (WHO) PERSPECTIVE. Luis Alfonzo (USA).

4.05 pm UNITED NATIONS OFFICE ON DRUGS AND CRIME (UNODC) DUAL DISORDERS AND COVID-19 THE UNOCD PERSPECTIVE. Elisabeth Saenz (UNODC).

4.08 pm PRISON AND DRUGS: AND THE IMPACT OF COVID-19 IN THE EUROPEAN PRISONS. Linda Montanari (EMCDDA).

4.11 pm NIDA. DUAL DISORDERS AND COVID-19 THE US EXPERIENCE
Nora Volkow (USA).

4.21 pm IV WADD CONGRESS: MARRAKECH (OCTOBER 22 TO 24, 2020) Mehdi Paes (Morocco).

QUESTION & ANSWERS

4.26 pm Q&A AND FINAL REMARKS.
Nestor Szerman (Spain) and Icro Maremmani (Italy).

Related post